It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Shigella sonnei causes shigellosis, a severe gastrointestinal illness that is sexually transmissible among men who have sex with men (MSM). Multidrug resistance in S. sonnei is common including against World Health Organisation recommended treatment options, azithromycin, and ciprofloxacin. Recently, an MSM-associated outbreak of extended-spectrum β-lactamase producing, extensively drug resistant S. sonnei was reported in the United Kingdom. Here, we aimed to identify the genetic basis, evolutionary history, and international dissemination of the outbreak strain. Our genomic epidemiological analyses of 3,304 isolates from the United Kingdom, Australia, Belgium, France, and the United States of America revealed an internationally connected outbreak with a most recent common ancestor in 2018 carrying a low-fitness cost resistance plasmid, previously observed in travel associated sublineages of S. flexneri. Our results highlight the persistent threat of horizontally transmitted antimicrobial resistance and the value of continuing to work towards early and open international sharing of genomic surveillance data.
An increase in shigellosis cases among men who have sex with men in the United Kingdom has been linked to an extensively drug-resistant strain of Shigella sonnei. In this genomic epidemiology study, the authors investigate the genetic basis, evolutionary history, and international dissemination of the outbreak strain.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details











1 NIHR HPRU in Gastrointestinal Infections at University of Liverpool, Liverpool, UK (GRID:grid.10025.36) (ISNI:0000 0004 1936 8470); Veterinary and Ecological Sciences, Department of Clinical Infection, Microbiology, and Immunology; Institute for Infection, Liverpool, UK (GRID:grid.10025.36)
2 UK Health Security Agency, Gastro and Food Safety (One Health) Division, London, UK (GRID:grid.515304.6) (ISNI:0000 0005 0421 4601)
3 University of Bath, Milner Centre for Evolution, Bath, UK (GRID:grid.7340.0) (ISNI:0000 0001 2162 1699)
4 The Westmead Institute for Medical Research, Centre for Infectious Diseases and Microbiology, Westmead, Australia (GRID:grid.476921.f); Western Sydney Local Health District, Westmead, Australia (GRID:grid.482212.f) (ISNI:0000 0004 0495 2383); University of Sydney, Faculty of Medicine and Health, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X); University of Sydney, Sydney Infectious Diseases Institute, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X)
5 University of Sydney, Faculty of Medicine and Health, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X); New South Wales Health Pathology, Dee Why, Australia (GRID:grid.1013.3)
6 Veterinary and Ecological Sciences, Department of Clinical Infection, Microbiology, and Immunology; Institute for Infection, Liverpool, UK (GRID:grid.1013.3)
7 University of Sydney, Faculty of Medicine and Health, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X); University of Sydney, Sydney Infectious Diseases Institute, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X); New South Wales Health Pathology, Dee Why, Australia (GRID:grid.1013.3); Douglass Hanly Moir Pathology, Macquarie Park, Australia (GRID:grid.410690.a) (ISNI:0000 0004 0631 2320)
8 Western Sydney Local Health District, Westmead, Australia (GRID:grid.482212.f) (ISNI:0000 0004 0495 2383); University of Sydney, Faculty of Medicine and Health, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X); New South Wales Health Pathology, Dee Why, Australia (GRID:grid.1013.3)
9 The Westmead Institute for Medical Research, Centre for Infectious Diseases and Microbiology, Westmead, Australia (GRID:grid.476921.f); Western Sydney Local Health District, Westmead, Australia (GRID:grid.482212.f) (ISNI:0000 0004 0495 2383); University of Sydney, Sydney Infectious Diseases Institute, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X)
10 The Westmead Institute for Medical Research, Centre for Infectious Diseases and Microbiology, Westmead, Australia (GRID:grid.476921.f); Western Sydney Local Health District, Westmead, Australia (GRID:grid.482212.f) (ISNI:0000 0004 0495 2383); University of Sydney, Faculty of Medicine and Health, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X); University of Sydney, Sydney Infectious Diseases Institute, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X); New South Wales Health Pathology, Dee Why, Australia (GRID:grid.1013.3); Westmead Hospital, Centre for Infectious Diseases and Microbiology – Public Health, Institute for Clinical Pathology and Microbiology Research, Westmead, Australia (GRID:grid.413252.3) (ISNI:0000 0001 0180 6477)
11 The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X)
12 Université Paris Cité, Unité des Bactéries pathogènes entériques, Centre National de Référence des Escherichia coli, Shigella et Salmonella, Institut Pasteur, Paris, France (GRID:grid.508487.6) (ISNI:0000 0004 7885 7602)
13 Division of Human Bacterial Diseases, Sciensano, Ixelles, Belgium (GRID:grid.508031.f)